Citation: Bh. Kushner et Pa. Meyers, How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review, J CL ONCOL, 19(3), 2001, pp. 870-880
Citation: Bh. Kushner et al., Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma, J CL ONCOL, 19(22), 2001, pp. 4189-4194
Authors:
Kushner, BH
Yeung, HWD
Larson, SM
Kramer, K
Cheung, NKV
Citation: Bh. Kushner et al., Extending positron emission tomography scan utility to high-risk neuroblastoma: Fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients, J CL ONCOL, 19(14), 2001, pp. 3397-3405
Authors:
Kushner, BH
Wolden, S
LaQuaglia, MP
Kramer, K
Verbel, D
Heller, G
Cheung, NKV
Citation: Bh. Kushner et al., Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery, J CL ONCOL, 19(11), 2001, pp. 2821-2828
Authors:
Kushner, BH
Cheung, NKV
Kramer, K
Dunkel, IJ
Calleja, E
Boulad, F
Citation: Bh. Kushner et al., Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in childrenand young adults, BONE MAR TR, 28(6), 2001, pp. 551-556
Authors:
Kramer, K
Gerald, WL
Kushner, BH
Larson, SM
Hameed, M
Cheung, NKV
Citation: K. Kramer et al., Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 194-196
Authors:
Cheung, NKV
Kushner, BH
LaQuaglia, M
Kramer, K
Gollamudi, S
Heller, G
Gerald, W
Yeh, S
Finn, R
Larson, SM
Wuest, D
Byrnes, M
Dantis, E
Mora, J
Cheung, IY
Rosenfield, N
Abramson, S
O'Reilly, RJ
Citation: Nkv. Cheung et al., N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age, MED PED ONC, 36(1), 2001, pp. 227-230
Authors:
Mora, J
Cheung, NKV
Kushner, BH
LaQuaglia, MP
Kramer, K
Fazzari, M
Heller, G
Chen, LS
Gerald, WL
Citation: J. Mora et al., Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p, J MOL DIAGN, 2(1), 2000, pp. 37-46
Authors:
Kushner, BH
Kramer, K
Meyers, PA
Wollner, N
Cheung, NKV
Citation: Bh. Kushner et al., Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors, MED PED ONC, 35(5), 2000, pp. 468-474
Authors:
Megonigal, MD
Cheung, NKV
Rappaport, EF
Nowell, PC
Wilson, RB
Jones, DH
Addya, K
Leonard, DGB
Kushner, BH
Williams, TM
Lange, BJ
Felix, CA
Citation: Md. Megonigal et al., Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors, P NAS US, 97(6), 2000, pp. 2814-2819
Authors:
Kushner, BH
Heller, G
Kramer, K
Cheung, NKV
Citation: Bh. Kushner et al., Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma, CANCER, 89(10), 2000, pp. 2122-2130
Citation: Bh. Kushner et al., Institutional review board review of research reported in the Journal of Clinical Oncology - Reply 2, J CL ONCOL, 17(8), 1999, pp. 2626-2626
Authors:
Merchant, TE
Kushner, BH
Sheldon, JM
LaQuaglia, M
Healey, JH
Citation: Te. Merchant et al., Effect of low-dose radiation therapy when combined with surgical resectionfor Ewing sarcoma, MED PED ONC, 33(2), 1999, pp. 65-70
Authors:
Cheung, NKV
Heller, G
Kushner, BH
Kramer, K
Citation: Nkv. Cheung et al., Detection of neuroblastoma in bone marrow by immunocytology: Is a single marrow aspirate adequate?, MED PED ONC, 32(2), 1999, pp. 84-87
Authors:
Cole, P
Ladanyi, M
Gerald, WL
Cheung, NKV
Kramer, K
LaQuaglia, MP
Kushner, BH
Citation: P. Cole et al., Synovial sarcoma mimicking desmoplastic small round-cell tumor: Critical role for molecular diagnosis, MED PED ONC, 32(2), 1999, pp. 97-101
Authors:
Kushner, BH
Cheung, NKV
Kramer, K
Heller, G
Jhanwar, SC
Citation: Bh. Kushner et al., Neuroblastoma and treatment-related myelodysplasia/leukemia: The Memorial Sloan-Kettering experience and a literature review, J CL ONCOL, 16(12), 1998, pp. 3880-3889